Pcn185 - Cost-Effectiveness of Nivolumab in Second-Line Treatment of Locally Advanced Unresectable or Metastatic Urothelial Carcinoma in Adults After Failure of Prior Platinum-Containing Therapy in Greece
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.268
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV